Social enterprise, Lucky Iron Fish, completes Series A Funding with a new investment from Danone Communities to better help address iron deficiency
October 25, 2021 07:50 ET
|
Lucky Iron Fish
Toronto, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Toronto, ON (Oct 22, 2021) — Lucky Iron Fish Enterprise (LIFe) is pleased to announce the completion of a $1 Million Series A funding, led by Danone...
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 01:00 ET
|
ObsEva SA
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
July 20, 2021 08:31 ET
|
Femasys Inc.
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Lucky Iron Fish receives $250k in funding to help address iron deficiency anemia in Benin.
June 30, 2021 12:32 ET
|
Lucky Iron Fish
Toronto, June 30, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) is an impact-driven company that is on a mission to tackle iron deficiency globally using their innovative solutions...
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
February 19, 2021 08:35 ET
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories
May 17, 2019 08:30 ET
|
Bio-Reference Laboratories
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of...
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions
May 02, 2019 17:05 ET
|
Bio-Reference Laboratories
Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
March 14, 2018 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
March 12, 2018 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months and year ended...
Sona Jasani, MD is Honored by the American Health Council for “Best in Medicine”
February 14, 2018 08:00 ET
|
American Health Council
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Sona Jasani, MD as one of “America’s Best Doctors” for her unparalleled professional dedication and...